Risk Factors for Intraocular Lens Dislocation Requiring Surgical Intervention After Initial Phacoemulsification Cataract Surgery

初次超声乳化白内障手术后发生晶状体脱位需再次手术干预的危险因素

阅读:2

Abstract

BACKGROUND/AIMS: To identify pre-, intra-, and postoperative risk factors for developing IOL dislocation that required surgical intervention for IOL dislocation after an initial planned phacoemulsification cataract surgery. METHODS: A retrospective multicenter clinical database study collected over 12 years from 8 clinical centers in the United Kingdom. We included all eyes that underwent planned phacoemulsification cataract surgery. We excluded eyes that underwent planned large incision cataract surgery, were left aphakic during initial surgery and those that underwent retina or other intraocular surgery between initial cataract surgery and development of IOL dislocation. We used the Poisson model with robust approximation of variance for multivariable estimations to calculate adjusted relative risk (ARR). RESULTS: Of 176,572 eyes that underwent planned phacoemulsification cataract surgery, 145 (0.08%) developed IOL dislocation requiring surgery. Factors that increased the risk for developing IOL dislocation included age between 18 and 40 years (ARR = 4.5 [1.7-12.0]), age between 40 and 60 years (ARR = 2.6 [1.6-4.5]), male sex (ARR = 1.5 [1.1-2.1]), pseudoexfoliation (ARR = 5.7 [3.1-10.5]), zonular dialysis (ARR = 3.3 [1.5-7.1]), posterior capsule rupture (PCR) (ARR = 16.4 [9.7-27.1]), iris damage (ARR = 4.2 [1.5-11.6]), combined phacoemulsification-pars plana vitrectomy (ARR = 3.2 [1.7-6.2]), and YAG capsulotomy (ARR = 2.8 [1.5-5.2]) (p < 0.05 for all). CONCLUSION: This large database study quantified the risk factors for IOL dislocation after cataract surgery. This information is clinically useful for surgeons for preoperative risk stratification and surgical planning.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。